文献速递甲状腺疾病

评估美国普通人群对甲状腺癌的恐惧:一项横断面研究

Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.
PubMed 文献 · Thyroid · 2024-01-12

该研究通过在线平台于2020年8月对美国成年人进行横断面调查,使用改编的乳腺癌恐惧量表测量甲状腺癌特异性恐惧。1136名受访者中47.5%存在高水平恐惧,年龄<40岁、女性、认为甲状腺癌或癌症总体严重、高估发病率及自认患癌风险高与高水平恐惧相关。

要点

  • 美国成年人中甲状腺癌特异性恐惧普遍,47.5%受访者存在高水平恐惧。
  • 年龄<40岁(OR=2.46)和女性(OR=1.48)与高水平恐惧相关。
  • 认为甲状腺癌严重(OR=2.71)、高估发病率(OR=1.64)及自认患癌风险高(OR=1.70)与高水平恐惧相关。

核心结论

  • 甲状腺癌特异性恐惧在美国成年人中普遍存在,尤其在女性和40岁以下人群中。
  • 由于疾病特异性恐惧与过度治疗相关,针对甲状腺癌严重性、发病率和风险因素的教育可能降低公众恐惧并可能减少与「恐惧决策」相关的过度治疗。

研究设计与样本

  • 横断面调查,使用Prolific Academic Ltd.在线平台于2020年8月对美国英语成人(>17岁)进行调查,样本按美国人口 demographics 分层。
  • 共1136名受访者(94.3%合格率),50.4%女性,74.1%白人,平均年龄45岁(SD=16岁)。
  • 使用改编的八项乳腺癌恐惧量表测量甲状腺癌特异性恐惧,多变量逻辑回归识别与高水平恐惧显著相关的因素。

主要发现

  • 47.5%受访者存在高水平甲状腺癌特异性恐惧。
  • 年龄<40岁 vs 65+岁:OR=2.46(95%CI 1.60-3.80);女性 vs 男性:OR=1.48(95%CI 1.13-1.93)。
  • 认为甲状腺癌严重:OR=2.71(95%CI 1.99-3.69);认为癌症总体严重:OR=1.53(95%CI 1.13-2.08)。
  • 高估甲状腺癌发病率:OR=1.64(95%CI 1.25-2.13);自认患癌风险高:OR=1.70(95%CI 1.19-2.42)。

临床怎么用

  • 作者认为,针对甲状腺癌严重性、发病率和风险因素的教育可能降低公众恐惧,并可能减少与「恐惧决策」相关的过度治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: This study aimed to measure fear of thyroid cancer in the general U.S. population and identify factors associated with a high level of thyroid cancer-specific fear that may contribute to overtreatment. Methods: We conducted a cross-sectional survey using Prolific Academic Ltd.®, an online survey platform. The survey was administered in August 2020 to English speaking adults (>17 years) in the United States who were registered with Prolific. The target sample was stratified to represent the demographics of the U.S. population. A validated, eight-item breast cancer fear scale was adapted to measure thyroid cancer-specific fear. Multivariate logistic regression identified factors significantly associated with high levels of thyroid cancer-specific fear. Results: Of the 1136 respondents (94.3% eligibility), 50.4% were female, 74.1% White, and the mean age was 45 years (SD = 16 years). Overall, 47.5% of respondents had high levels of thyroid cancer-specific fear. Multivariate regression demonstrated that age <40 years (OR = 2.46 vs. 65+ [95% confidence interval {CI} = 1.60-3.80]) and female gender (OR = 1.48 vs. male [CI = 1.13-1.93]) were associated with high levels of thyroid cancer fear. Believing thyroid cancer (OR = 2.71 [CI = 1.99-3.69]) and cancer in general are serious (OR = 1.53 [CI = 1.13-2.08]) were also associated with high levels of thyroid cancer fear. Respondents who overestimated thyroid cancer incidence (OR = 1.64 [CI = 1.25-2.13]) and believed they had a high chance of developing cancer (OR = 1.70 [CI = 1.19-2.42]) were also more likely to have high fear of thyroid cancer. Conclusion: Thyroid cancer-specific fear is prevalent in U.S. adults particularly in females and those younger than 40 years. Because disease-specific fear is associated with overtreatment, targeted education about the seriousness, incidence, and risk factors for developing thyroid cancer may decrease public fear and possibly overtreatment related to "scared decision-making."

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Taylor SR, Chiu A, Hoxha I, et al. Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study. Thyroid. 2024. PMID: 38115606. doi:10.1089/thy.2023.0479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。